Similarly, the selective progesterone receptor modulator ulipristal acetate (UPA) inhibits NFAT5 concomitantly with a decrease in versican, aggrecan, and brevican proteoglycans, leading to a significant decrease in leiomyoma tissue 351. This evidence concerns the gene NFAT5 and leiomyoma.